Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Tran

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|February 16, 2012
Hepatitis C virus cure as motivation for alcohol withdrawal?Régine Truchi, Eve Gelsi, Faredj Cherikh, et al.
Journal of Hepatology|February 5, 2013
Reply to: "regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD"Rodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
Surgery|October 12, 2010
Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomyAntonio Iannelli, Rodolphe Anty, Anne Sophie Schneck, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover studyGilles Pomier-Layrargues, Sarto C Paquin, Ziad Hassoun, et al.
Gastroenterologie Clinique Et Biologique|May 22, 2003
[Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district]Denis Ouzan, Philippe Cavailler, Philippe Hofliger, et al.
Gastroenterologie Clinique Et Biologique|January 8, 2008
[Metabolic fatty liver diseases: hepatic consequences of the metabolic syndrome]Rodolphe Anty, Philippe Gual, Pierre-Michel Huet, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV PatientsMagdalena Meszaros, Régine Truchi, Denis Ouzan, et al.
Clinics and Research in Hepatology and Gastroenterology|November 4, 2015
Nonalcoholic steatohepatitis cirrhosis and type 1 refractory celiac disease: More than a fortuitous association?Audrey Hastier, Stéphanie Patouraux, Clémence M Canivet, et al.
Current Obesity Reports|June 25, 2025
Incretins and MASLD: at the Crossroads of Endocrine and Hepatic DisordersMarwin A Farrugia, Enzo Pini, Albert Tran, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2022
Infectious complications of portal biliopathy leading to liver transplantationThomas Levi-Strauss, Geoffroy Vanbiervliet, Patrick Chevallier, et al.
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|February 16, 2012
Hepatitis C virus cure as motivation for alcohol withdrawal?Régine Truchi, Eve Gelsi, Faredj Cherikh, et al.
Journal of Hepatology|February 5, 2013
Reply to: "regular coffee: a magic bullet or a naked gun? Regular coffee but not espresso drinking is protective against fibrosis in NAFLD"Rodolphe Anty, Sophie Marjoux, Antonio Iannelli, et al.
Surgery|October 12, 2010
Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomyAntonio Iannelli, Rodolphe Anty, Anne Sophie Schneck, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover studyGilles Pomier-Layrargues, Sarto C Paquin, Ziad Hassoun, et al.
Gastroenterologie Clinique Et Biologique|May 22, 2003
[Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district]Denis Ouzan, Philippe Cavailler, Philippe Hofliger, et al.
Gastroenterologie Clinique Et Biologique|January 8, 2008
[Metabolic fatty liver diseases: hepatic consequences of the metabolic syndrome]Rodolphe Anty, Philippe Gual, Pierre-Michel Huet, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV PatientsMagdalena Meszaros, Régine Truchi, Denis Ouzan, et al.
Clinics and Research in Hepatology and Gastroenterology|November 4, 2015
Nonalcoholic steatohepatitis cirrhosis and type 1 refractory celiac disease: More than a fortuitous association?Audrey Hastier, Stéphanie Patouraux, Clémence M Canivet, et al.
Current Obesity Reports|June 25, 2025
Incretins and MASLD: at the Crossroads of Endocrine and Hepatic DisordersMarwin A Farrugia, Enzo Pini, Albert Tran, et al.
Clinics and Research in Hepatology and Gastroenterology|February 13, 2022
Infectious complications of portal biliopathy leading to liver transplantationThomas Levi-Strauss, Geoffroy Vanbiervliet, Patrick Chevallier, et al.
Pageof 19